Gillies Donna, Taylor Fiona, Gray Carl, O'Brien Louise, D'Abrew Natalie
Western Sydney and Nepean Blue Mountains Local Health Districts - Mental Health, Parramatta, Australia.
Evid Based Child Health. 2013 May;8(3):1004-116. doi: 10.1002/ebch.1916.
Post-traumatic stress disorder (PTSD) is highly prevalent in children and adolescents who have experienced trauma and has high personal and health costs. Although a wide range of psychological therapies have been used in the treatment of PTSD there are no systematic reviews of these therapies in children and adolescents.
To examine the effectiveness of psychological therapies in treating children and adolescents who have been diagnosed with PTSD.
We searched the Cochrane Depression, Anxiety and Neurosis Review Group's Specialised Register (CCDANCTR) to December 2011. The CCDANCTR includes relevant randomised controlled trials from the following bibliographic databases: CENTRAL (the Cochrane Central Register of Controlled Trials) (all years), EMBASE (1974 -), MEDLINE (1950 -) and PsycINFO (1967 -). We also checked reference lists of relevant studies and reviews. We applied no date or language restrictions.
All randomised controlled trials of psychological therapies compared to a control, pharmacological therapy or other treatments in children or adolescents exposed to a traumatic event or diagnosed with PTSD.
Two members of the review group independently extracted data. If differences were identified, they were resolved by consensus, or referral to the review team. We calculated the odds ratio (OR) for binary outcomes, the standardised mean difference (SMD) for continuous outcomes, and 95% confidence intervals (CI) for both, using a fixed-effect model. If heterogeneity was found we used a random-effects model.
Fourteen studies including 758 participants were included in this review. The types of trauma participants had been exposed to included sexual abuse, civil violence, natural disaster, domestic violence and motor vehicle accidents. Most participants were clients of a trauma-related support service. The psychological therapies used in these studies were cognitive behavioural therapy (CBT), exposure-based, psychodynamic, narrative, supportive counselling, and eye movement desensitisation and reprocessing (EMDR). Most compared a psychological therapy to a control group. No study compared psychological therapies to pharmacological therapies alone or as an adjunct to a psychological therapy. Across all psychological therapies, improvement was significantly better (three studies, n = 80, OR 4.21, 95% CI 1.12 to 15.85) and symptoms of PTSD (seven studies, n = 271, SMD -0.90, 95% CI -1.24 to -0.42), anxiety (three studies, n = 91, SMD -0.57, 95% CI -1.00 to -0.13) and depression (five studies, n = 156, SMD -0.74, 95% CI -1.11 to -0.36) were significantly lower within a month of completing psychological therapy compared to a control group. The psychological therapy for which there was the best evidence of effectiveness was CBT. Improvement was significantly better for up to a year following treatment (up to one month: two studies, n = 49, OR 8.64, 95% CI 2.01 to 37.14; up to one year: one study, n = 25, OR 8.00, 95% CI 1.21 to 52.69). PTSD symptom scores were also significantly lower for up to one year (up to one month: three studies, n = 98, SMD -1.34, 95% CI -1.79 to -0.89; up to one year: one study, n = 36, SMD -0.73, 95% CI -1.44 to -0.01), and depression scores were lower for up to a month (three studies, n = 98, SMD -0.80, 95% CI -1.47 to -0.13) in the CBT group compared to a control. No adverse effects were identified. No study was rated as a high risk for selection or detection bias but a minority were rated as a high risk for attrition, reporting and other bias. Most included studies were rated as an unclear risk for selection, detection and attrition bias.
AUTHORS' CONCLUSIONS: There is evidence for the effectiveness of psychological therapies, particularly CBT, for treating PTSD in children and adolescents for up to a month following treatment. At this stage, there is no clear evidence for the effectiveness of one psychological therapy compared to others. There is also not enough evidence to conclude that children and adolescents with particular types of trauma are more or less likely to respond to psychological therapies than others. The findings of this review are limited by the potential for methodological biases, and the small number and generally small size of identified studies. In addition, there was evidence of substantial heterogeneity in some analyses which could not be explained by subgroup or sensitivity analyses. More evidence is required for the effectiveness of all psychological therapies more than one month after treatment. Much more evidence is needed to demonstrate the relative effectiveness of different psychological therapies or the effectiveness of psychological therapies compared to other treatments. More details are required in future trials in regards to the types of trauma that preceded the diagnosis of PTSD and whether the traumas are single event or ongoing. Future studies should also aim to identify the most valid and reliable measures of PTSD symptoms and ensure that all scores, total and sub-scores, are consistently reported.
创伤后应激障碍(PTSD)在经历过创伤的儿童和青少年中极为普遍,且会带来高昂的个人和健康代价。尽管已有多种心理疗法用于治疗PTSD,但尚无针对儿童和青少年这些疗法的系统评价。
探讨心理疗法对已诊断为PTSD的儿童和青少年的治疗效果。
我们检索了截至2011年12月的Cochrane抑郁、焦虑与神经症综述小组专业注册库(CCDANCTR)。CCDANCTR包括来自以下书目数据库的相关随机对照试验:CENTRAL(Cochrane对照试验中心注册库)(所有年份)、EMBASE(1974年起)、MEDLINE(1950年起)和PsycINFO(1967年起)。我们还查阅了相关研究和综述的参考文献列表。我们未设日期或语言限制。
所有将心理疗法与对照组、药物疗法或其他治疗方法进行比较的随机对照试验,试验对象为经历过创伤事件或被诊断为PTSD的儿童或青少年。
综述小组的两名成员独立提取数据。若发现差异,则通过协商解决,或提交给综述团队。我们使用固定效应模型计算二分类结局的比值比(OR)、连续结局的标准化均数差(SMD)以及二者的95%置信区间(CI)。若发现异质性,则使用随机效应模型。
本综述纳入了14项研究,共758名参与者。参与者所经历的创伤类型包括性虐待、民间暴力、自然灾害、家庭暴力和机动车事故。大多数参与者是创伤相关支持服务的客户。这些研究中使用的心理疗法包括认知行为疗法(CBT)、基于暴露的疗法、心理动力学疗法、叙事疗法、支持性咨询以及眼动脱敏再处理疗法(EMDR)。大多数研究将心理疗法与对照组进行比较。没有研究将心理疗法单独与药物疗法进行比较,或作为心理疗法的辅助手段进行比较。在所有心理疗法中,改善情况显著更好(三项研究,n = 80,OR 4.21,95% CI 1.12至15.85),与对照组相比,完成心理治疗后一个月内,PTSD症状(七项研究,n = 271,SMD -0.90,95% CI -1.24至-0.42)、焦虑(三项研究,n = 91,SMD -0.57,95% CI -1.00至-0.13)和抑郁(五项研究,n = 156,SMD -0.74,95% CI -!1至-0.36)显著更低。有最佳疗效证据的心理疗法是CBT。治疗后长达一年改善情况显著更好(长达一个月:两项研究,n = 49,OR 8.64,95% CI 2!1至37.14;长达一年:一项研究,n = 25,OR 8.00,95% CI 1.21至52.69)。与对照组相比,CBT组长达一年的PTSD症状评分也显著更低(长达一个月:三项研究,n = 98,SMD -1.34,95% CI -1.79至-0.89;长达一年:一项研究,n = 36,SMD -0.73,95% CI -1.44至-0.01),抑郁评分在长达一个月内更低(三项研究,n = 98,SMD -0.80,95% CI -1.47至-0.13)。未发现不良反应。没有研究被评为存在选择或检测偏倚的高风险,但少数研究被评为存在失访、报告和其他偏倚的高风险。大多数纳入研究被评为在选择、检测和失访偏倚方面风险不明确。
有证据表明心理疗法,尤其是CBT,在治疗儿童和青少年PTSD方面治疗后长达一个月有效。现阶段,尚无明确证据表明一种心理疗法比其他疗法更有效。也没有足够证据得出结论,即患有特定类型创伤的儿童和青少年比其他儿童和青少年对心理疗法的反应更有可能或更不可能。本综述的结果受到方法学偏倚可能性的限制,以及已识别研究数量少且规模普遍较小的限制。此外,在一些分析中存在大量异质性的证据,无法通过亚组分析或敏感性分析来解释。治疗一个月后所有心理疗法有效性还需要更多证据。需要更多得多的证据来证明不同心理疗法的相对有效性,或心理疗法与其他治疗方法相比的有效性。未来试验需要更多关于PTSD诊断之前创伤类型的细节,以及这些创伤是单一事件还是持续存在的。未来研究还应旨在确定PTSD症状最有效和可靠的测量方法,并确保一致报告所有分数,总分和子分数。